Picture of Vicore Pharma Holding AB logo

VICO — Vicore Pharma Holding AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Vicore Pharma Q4 Oper Loss Widens To SEK 13.7 Mln; Aims To List On Nasdaq Main List

March 15 (Reuters) - Vicore Pharma Holding AB  VICOR.ST :
    * Q4 OPERATING INCOME AMOUNTED TO 0.1 MSEK (0.3)
    * Q4 OPERATING LOSS SEK 13.7 MILLION VERSUS LOSS SEK 9.1
MILLION
YEAR AGO
    * GOAL FOR 2019: UP-LIST TO STOCKHOLM NASDAQ MAIN LIST

Source text for Eikon:  ID:nWkr3GDqcL 
Further company coverage:  VICOR.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Vicore Pharma Holding AB

See all news